Viridian Therapeutics, Inc.\DE (VRDN) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Viridian Therapeutics, Inc.\DE insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $30.0M and 1 sold $419K of VRDN stock on the open market.
Get emailed when insiders cluster-buy stocks like VRDN
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
VRDN insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $348K | 2 |
| Q2 2026 | $20.0M | 1 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $10.0M | 1 | $71K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Viridian Therapeutics, Inc.\DE insiders reported open-market purchases totaling $30.0M, while 1 insider reported sales totaling $419K. 0 of 3 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 20SEC | Jennifer TousignantGeneral Counsel | Sell | 10,000 | $24.50 | $245K | -23.8% | — |
| Aug 20SEC | Jennifer TousignantGeneral Counsel | Sell | 4,212 | $24.50 | $103K | -23.8% | — |
| May 13SEC | Fairmount Healthcare Fund Ii L.P.Director | Buy | 1,176,4705,090,928 held (+30%) | $17.00 | $20.0M | +9.8% | — |
| Jan 2SEC | Jennifer TousignantGeneral Counsel | Sell | 2,272 | $31.16 | $71K | -40.1% | — |
| Oct 27SEC | Fairmount Healthcare Fund Ii Gp LlcDirector | Buy | 454,5453,914,458 held (+13%) | $22.00 | $10.0M | -15.2% | — |
Insiders at Viridian Therapeutics, Inc.\DE
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Fairmount Healthcare Fund Ii L.P.Director | $20.0M | — | May 13, 2026 | — |
| Fairmount Healthcare Fund Ii Gp LlcDirector | $10.0M | — | Oct 27, 2025 | — |
| Jennifer TousignantGeneral Counsel | — | $419K | Aug 20, 2026 | — |
VRDN stock: common questions
Are Viridian Therapeutics, Inc.\DE insiders buying VRDN stock?
In the past 12 months, 2 insiders reported open-market purchases of VRDN worth $30.0M. The latest was Director Fairmount Healthcare Fund Ii L.P. bought $20.0M of VRDN at $17.00 — first open-market purchase in our records; raises the stake by 30%.
Are Viridian Therapeutics, Inc.\DE insiders selling VRDN stock?
1 insiders reported sales worth $419K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is VRDN's 52-week range?
Over the past year VRDN has traded between $13.30 and $33.78. It last closed at $18.66 on Oct 9, 2026.